FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2. - Alina Renz; Lina Widerspick; Andreas Dräger (Bioinform., 2020)

New workflow predicts drug targets against SARS-CoV-2 via metabolic changes in infected cells. - Nantia Leonidou; Alina Renz; Reihaneh Mostolizadeh; Andreas Dräger (PLoS Comput. Biol., 2023)